目的:用直接偶联法构建新型蛋白兔抗人IgGCRM9.方法:分别应用异型双功能连接剂(m Maleimido benzoyl N hydoxysuccinimideester,MBS)和N琥珀酰亚胺3(2吡啶二巯基)丙酸盐(SPDP)将兔抗人IgG多抗和白喉毒素突变体(CRM9)进行连接,制备出新...目的:用直接偶联法构建新型蛋白兔抗人IgGCRM9.方法:分别应用异型双功能连接剂(m Maleimido benzoyl N hydoxysuccinimideester,MBS)和N琥珀酰亚胺3(2吡啶二巯基)丙酸盐(SPDP)将兔抗人IgG多抗和白喉毒素突变体(CRM9)进行连接,制备出新的蛋白.结合后的蛋白经SephacrylS300分离纯化,用聚丙烯酰胺凝胶电泳和琼脂糖电泳证明二者的结合情况.采用酶联免疫法检测IgG与CRM9按不同比例反应后所构建的蛋白复合体中抗体部分的活性.结果:用MBS连接剂连接IgG与CRM9后的产物经聚丙烯酰胺凝胶电泳显示出的条带明显滞后于IgG所显示的条带,而在琼脂糖凝胶电泳中IgG与CRM9混合反应的样品所显示的两条条带均与IgG和CRM9单独所在的条带一致.酶联免疫实验测得的各组A450nm值表明,IgG与CRM9按1∶1和1∶3两种比例制备的样品对抗体活性影响最小,而按1∶5和1∶两种比例制备的蛋白,抗体活性受到很大的抑制.结论:兔抗人IgG与CRM9可以通过MBS结合,二者在1∶1～1∶3之间的比例时,可以有较好的连接,而且对抗体活性的影响最小.SP DP则不适用于本实验中的两种蛋白的连接.这将为免疫毒素的新型连接提供有效的方法.展开更多
Background： Plasmodium falciparum malaria remains a major life-threatening disease. Recently, the Plasmodium apoptosis-linked pathogenicity factors （PALPF） have been identified. These antigens PALPF are expressed o...Background： Plasmodium falciparum malaria remains a major life-threatening disease. Recently, the Plasmodium apoptosis-linked pathogenicity factors （PALPF） have been identified. These antigens PALPF are expressed only by P falciparum-infected erythrocytes triggering endothelial cell apoptosis （apoptogenic）. Methods： We designed ten synthetic peptides （PI to P10） from PALPF： PF07 0032, PF10_0226, PFI0130c, PFD0875c and MAL13P1.206, and analyzed their antigenicity with an ELISA method using plasma samples from subjects living in Dienga, Gabon. Results： Four peptides showed good reactivity with human antibodies. The prevalence rate of specific IgG was 61%, 51%, 44% and 34% for P5, P6, P4 and P2, respectively. The median optical density of total IgG anti-P2 was higher than that directed against P4 and P6 （P = 0.009; P = 0.012 respectively）. The prevalence rate oflgG subclasses determined with plasma samples recognizing peptide 5 for IgGl, 2, 3 and 4 isotypes was 69%, 45%, 76% and 62%, respectively. All the subjects had at least one immunoglobulin subclass, while 13 （44%） had both IgG1 and IgG3 antibodies. There was no significant difference in the prevalence rate of anti-P5 IgG1, IgG3 and IgG4. Conclusion： These results warrant further immunogenicity studies of peptides 2, 4, 5 and 6 with a view of a tentative to antimalarial vaccine development.展开更多
文摘Background： Plasmodium falciparum malaria remains a major life-threatening disease. Recently, the Plasmodium apoptosis-linked pathogenicity factors （PALPF） have been identified. These antigens PALPF are expressed only by P falciparum-infected erythrocytes triggering endothelial cell apoptosis （apoptogenic）. Methods： We designed ten synthetic peptides （PI to P10） from PALPF： PF07 0032, PF10_0226, PFI0130c, PFD0875c and MAL13P1.206, and analyzed their antigenicity with an ELISA method using plasma samples from subjects living in Dienga, Gabon. Results： Four peptides showed good reactivity with human antibodies. The prevalence rate of specific IgG was 61%, 51%, 44% and 34% for P5, P6, P4 and P2, respectively. The median optical density of total IgG anti-P2 was higher than that directed against P4 and P6 （P = 0.009; P = 0.012 respectively）. The prevalence rate oflgG subclasses determined with plasma samples recognizing peptide 5 for IgGl, 2, 3 and 4 isotypes was 69%, 45%, 76% and 62%, respectively. All the subjects had at least one immunoglobulin subclass, while 13 （44%） had both IgG1 and IgG3 antibodies. There was no significant difference in the prevalence rate of anti-P5 IgG1, IgG3 and IgG4. Conclusion： These results warrant further immunogenicity studies of peptides 2, 4, 5 and 6 with a view of a tentative to antimalarial vaccine development.
